In Pharma Almanac’s recent industry leaders roundtable, Abzena’s CEO, Geoffrey Glass, shared his thoughts on how current geopolitical factors are influencing biopharma’s sourcing and manufacturing decisions for their complex supply chains.Geopolitical factors are having a bifurcated impact. U.S. pressure has certainly led biopharmaceutical companies to commit to U.S. factories, almost all of which